The Future of Biotech: The Role of Legislation within Investment for Innovation
2024-09-24 14:00 - 15:30 (Europe/Brussels)
To celebrate the start of European Biotech Week 2024, EuropaBio is organising a webinar to discuss the critical intersection of legislation and investment into innovation within the biotech industry. With clear political support for European leadership in biotech, ensuring EU legislation become key enabler of investment for innovation will be essential to the EU’s global competitiveness and strategic open autonomy.

This webinar will bring together representatives from the biotech industry, investor community, and European institutions to explore the essential elements required to foster a thriving biotech and life sciences ecosystem in the EU.

The confirmed speakers and full agenda are:

Welcome and introduction

Marica Nobile (Assobiotec Federchimica)

Keynote speech: EU biotech & biomanufacturing initiative

Hans Ingels (DG GROW)

Panel: Impact of EU Legislation on Investment Opportunities

Yordan Aleksandrov (Pfizer)

SME – Anna Handschuh (Future Affairs)

Nicoló Giacomuzzi-Moore (CBEJU)

Katrien Swerts (Kurma Partners)

Marica Nobile (Assobiotec Federchimica) will moderate the panel and deliver closing remarks.

Register Here

How does a Novel Food get to your plate?
2024-09-30 14:00 - 16:00
This EuropaBio’s webinar will focus on the pathway to market for Novel Foods, from initial development in R&D through to consumer uptake while going through risk assessment and approval. Each speaker will cover a key point along the value chain, including illustrative examples and case studies where relevant.

The event will be moderated by Hannah Lester, CEO at Atova Consulting.

The confirmed speakers are:

Muriel Dewilde, Business Development Manager, Bio Base Europe Pilot Plant

Ermolaos Ververis, Scientific Officer Nutrition & Food Innovation Unit, EFSA

Timen Van Haaster, Public Affairs & Communications Director, HollandBio

Anders Nelving, Line Solution Manager, Tetra Pak

Per Falholt, CSO at 21st Bio

Register Here

Europe's Biotechnology & Biomanufacturing Future
2024-10-01 17:00 - 20:00
Biotechnology is a critical technology for global economic security, health and sustainability.

Europe’s world-leading research is translated into medicines, food and next generation biomanufacturing across sectors in all European regions, with employment, skills and economic growth as part of a more sustainable, healthy, autonomous and competitive Europe.

The importance of biotechnology to Europe is now recognised through multiple actions. The European Commission Initiative “Boosting Biotechnology and Biomanufacturing in the EU” highlights the EU ambition to deliver biotechnology for competitiveness and societal impact alongside fast moving global regions, whilst the Letta report highlights its significance within a well-functioning single market. It is amplified further through its specific inclusion in legislations such as STEP and the Net Zero Industry Act.

EuropaBio, the voice of biotechnology industries in Europe, will be hosting this reception to explore how biotechnology is used across sectors. Invited guests will meet the European innovators that deliver and use biotechnology and understand how it benefits the quality of life of all EU citizens.

Innovative companies plus national and regional biotechnology associations will share their knowledge, and guests will network across EU Institutions and other key stakeholders to discover how the European Union builds the future of biotechnology.

For more information, contact: communications@europabio.org

Enhancing Europe's Pharma and Biotech Competitiveness and Open Strategic Autonomy
2024-10-02 17:00 - 19:30
Join our Director General Dr Claire Skentelbery on 2 October 2024 where she will be speaking at the Novartis & BritCham event “Enhancing Europe’s Pharma and Biotech Competitiveness and Open Strategic Autonomy”.

Find Out More & Register Here

CPHI Milan
2024-10-08 10:00 - 2024-10-10 18:00
EuropaBio is pleased to partner with CPHI Milan 2024, the biggest international pharmaceutical industry event for the thirty fifth anniversary edition. This year’s edition held from the 8th to the 10th of October in Fiera Milano, Italy promises to a packed agenda with over 150 expert international speakers with over 100 content sessions.

Join our Director General Dr Claire Skentelbery this year where she will be speaking on the 9th of October to discuss how cultivated meat has the potential to revolutionise biologic manufacturing. Join her in Hall 3 – 3F97 at 16:15 on 09/10/2024 to find out more.

Find Out More & Register Here

World Orphan Drug Congress Europe 2024
2024-10-22 08:00 - 2024-10-25 17:00
The World Orphan Drug Congress Europe is the largest and most established orphan drug & rare disease event worldwide. Meet over 2000 attendees, hear from 250 leading speakers, and connect with 130 exhibitors as we bring together experts from the start-to-finish of orphan drugs. From regulation and policy to global pricing and gene therapy, the Congress has it covered.

Our attendees include the most senior individuals across the industry, including; R&D, Gene Therapy and Rare diseases, Precision/Personalised Medicine, Genetic Disorders, Patient Advocacy and Engagement, Associations in ATMPs, Investors, Regulatory Affairs Professionals, Governmental Bodies and many more …

Use code “EUBIO20” to save an additional 20% off the Pharma/Biotech and Standard packages.

Regulating the Future of Food Conference
2024-10-23 08:00 - 2024-10-24 20:00
Join our Industrial Biotechnology Senior Manager Lucie McMurtry on the 23rd and 24th of October in Amsterdam where she will be speaking at the Regulating the Future of Food Conference.

Global innovation in food-tech is growing at an incredible pace and there are so many amazing new products and processes out there! This innovation is vital in making a difference to the planet by creating more sustainable and ‘greener’ food systems, whilst also contributing to economic growth.

Regulators are doing their best to keep up. They are all working on ways to evolve in line with innovation and create more effective and efficient ways to regulate novel foods, whilst keeping safety as the key priority. However, regulations are often seen as a barrier to innovation due to complex frameworks, a lack of clear guidance and long evaluation timelines.

More Info Here

BIO-Europe® 2024
2024-11-04 08:00 - 2024-11-06 20:00
BIO-Europe® 2024 – 30th Annual International Partnering Conference

Dates:November 4-6, 2024 | Stockholm, SwedenNovember 12–13, 2024 | Digital PartneringVenue: Stockholmsmässan

Venue address: Mässvägen 1, 125 80 Stockholm Sweden

Join the 30th anniversary edition of BIO-Europe, the biopharma partnering event that has grown with the industry, innovated alongside it, and remains the gathering place for meaningful and memorable conversations and connections. In 2023, BIO-Europe reached new levels of attendance, engagement, and collaboration. 2024 promises to deliver quality opportunities for connection and partnering. The 30th annual BIO-Europe will take place November 4-6, 2024 in Stockholm, Sweden, and it will convene over 5,500 life science professionals representing more than 2,800 companies from over 60 countries. Attendees will take part in 29,000 one-to-one meetings over the course of the event.

More Info Here

Advancing bio-based innovations in the food industry: Focus on fermentation
2024-11-12 09:00 - 12:30
Join our Director General Dr Claire Skentelbery on the 12th of November in Brussels where she will be speaking at the DG GROW hosted hybrid workshop “Advancing bio-based innovations in the food industry: Focus on fermentation”.

The workshop will focus on the industrial applications of fermentation technologies by highlighting SMEs that are using biomass, precision and gas fermentation. Their innovative technologies will be presented, along with ways to promote scaling up production. These presentations will be followed by a Q&A session.

After these industry insights, a panel of experts will discuss topics such as research and innovation, infrastructure, the role of farmers, public acceptance, market development, and profitability and pricing. In addition to the fermentation types presented at the beginning of the workshop, micro fermentation will be discussed.

Deadline for registrations: 4 November 2024

More Information & Register Here

SME roundtable: Towards globally competitive European SMEs
2024-11-19 00:00 - 23:59
Europe is home to a vibrant community of Biotechnology SMEs contributing to the modernisation of the European industry. European biotechnology SMEs are the main drivers for innovation in healthcare, food and feed, industrial processes and manufacturing.

The Initiative on “Boosting Biotechnology and Biomanufacturing in the EU” published by the European Commission in March 2024 provides great prospects for EU SMEs. It highlights the EU ambition to deliver the benefits of biotechnology to support EU competitiveness and innovation alongside other global regions. One objective of the initiative is to identify ways to streamline EU legislation and its implementation to reduce Single Market fragmentation, explore potential simplification of regulatory processes, and shortening the time to market of biotechnological innovations.

In order to meet this objective, EuropaBio, the voice of biotechnology industries in Europe, will be hosting this roundtable to work as partners with all relevant stakeholders to guarantee the success of this Initiative. This roundtable session aims to provide a discussion forum for SME participants active in the sector to share their main driving forces and obstacles to accessing global markets and supply chains. The session will explore the essential elements required to speed up EU market access of biotech products.

This event will be followed by a dedicated report exploring the sessions outcomes.

For more information, contact: communications@europabio.org

AseBio Green Innovation Forum
2024-11-19 08:00 - 20:00
Organized by AseBio, the Spanish Bioindustry Association, and Sodena the financial agent of the Government of Navarra, the 5th edition of the AseBio Green Innovation Forum will be held in the Baluarte convention centerof Pamplona on November 19, 2024. The event will showcase the opportunities that biotechnology can offer as a key tool in the transition towards a more sustainable, carbon neutral and greener economic model. The Green Innovation Forum is also firmly committed to achieving the objectives set out in the 2030 Agenda and the European Green Deal. The AseBio Green Innovation Forum will have an agenda of round tables and business meetings in which to address the most relevant aspects of innovation in biotechnology and the green economy. We will also seek to find solutions to medium-long term challenges such as climate change, industrial transformation, sustainable food, or the development of bio-products, among others. RegistrationRegistration for the Green Innovation Forum 24 is now open. Take advantage of the early bird rates until July 31st.

Present your companyCompanies that are members of AseBio or domiciled in Navarra can submit a proposal to present their company before an audience of specialized investors and companies at no extra cost of your registration fee. Sinx-minute presentations will be delivered onsite on November 19th, 2024. Not all applications will be accepted. A selection committee will review and accept or decline all applications. The deadline to apply: is September 20, 2024

If you wish to become a member of AseBio please visit our website.

Sponsorship opportunities

Do you wish to become a sponsor of the Green Innovation Forum?

Greeen Innovation Forum 2024 will provide you with a unique opportunity to meet face-to-face within Spanish and international cutting edge companies and research institutions in the green biotech space.

Sponsoring the event will help to create interest in your company, products and services and also:

Raise your profile within the Spanish and European biotech industry.

Other benefits, as included in the different sponsorship packages.

More Info Here

What's Next for Biotech & Biosecurity: EU & US Post Election Landscape
2024-11-22 14:00 - 16:00
Join our Healthcare Public Affairs Director, Vlad Olteanu on Friday 22nd November to listen to What’s next for Biotech and Biosecurity in the EU & US post elections.

More information & Registerion Here

The European Bioplastics Conference 2024
2024-12-10 08:00 - 2024-12-11 20:00
We are happy to announce that the EBC 24 will take place on 10/11 December 2024 at the Titanic Hotel Berlin, Germany.

The European Bioplastics Conference is Europe’s leading business and discussion forum within the global bioplastics sector. More and more brands and manufacturers are embracing the potential of biopolymers, and policy makers are increasingly streamlining their efforts to create frameworks that benefit the growth of sustainable bio-industries. Now is the time to put bioplastics at the top of the agenda of a biobased circular economy in Europe and beyond.

The registration for the EBC 24 is now open and we are excited to welcome you on 10/11 December 2024 in Berlin or online.

The hybrid format of this year’s event will again allow you to join either in person at the Titanic Hotel Berlin or comfortably log-in from your home base. Both of which offer unique networking opportunities.

More Info Here

2nd ESAB Digital Congress
2024-12-25 08:00 - 2024-12-27 20:00
After the successful first digital ESAB Congress last year, the Scientific Committee has decided that a digital ESAB congress will take place again this year from November 25-27.

Deadline for abstract submission: 31 October 2024

ESAB Aims

to take initiatives in areas of growing scientific and industrial interest and importance in the field of applied biocatalysis

to identify key topics which may be rate-limiting in the development of scientific progress and technological prospects in applied biocatalysis and to take steps to stimulate these areas

More Info Here

EU Health Summit
2025-01-28 14:00 - 18:00
Healthy populations are essential for Europe to achieve its vision of a secure, competitive, and prosperous continent. Yet, European health systems are navigating a perfect storm: ageing populations, rising chronic diseases, and a health workforce under strain. European societies are facing combined cost-of-living, geopolitical, and climate crises with significant implications for healthcare.

Amid these challenges, we must not lose sight of the extraordinary era we are living in—one of rapidly advancing science and innovation, transforming health and unlocking new possibilities for Europe’s present and future generations.

Keeping the health sector high on the political agenda is essential for the well-being of Europeans, a resilient workforce, the growth of the EU economy, and the security of Europe. This is why, during this EU mandate, we need a robust and integrated strategy for health policy.

What needs to be done in practice?

Join the EU Health Summit on 28 January to help shape a roadmap for a healthier Europe.

Register Here

A Driver of European Competitiveness: The Future of European Biotech
2025-01-29 18:30 - 20:30
EuropaBio, the European association representing Bioindustries, will host an evening reception co-hosted by MEP Stine Bosse (Vice-Chair, SANT) and MEP Eszter Lakos (Member, ITRE), to discuss the role of the European biotech sector in making the European industry more competitive.

Ambassador Søren Jacobsen, Deputy Permanent Representative of Denmark to the EU, and Kristin Schreiber, Director at DG GROW, Klaus Berend, Director SANTE will share some remarks on their approach to the biotech sector in the new mandate.

This event is only open to EuropaBio members & invited guests, to find out more about EuropaBio membership, contact us through our website here.

B-Trust’s 2nd masterclass: Co-Creating Trust in Biotech – Cell Factories
2025-02-28 09:00 - 10:30
How can biotechnology help shape a more sustainable food system? While scientific advancements are creating greener and more innovative ingredients, gaining consumer trust remains a key challenge.In this exclusive online masterclass, we’ll explore the role of cell factories – microorganisms that produce specialty food ingredients through fermentation – and their potential to revolutionise food production while reducing land use, water consumption, and carbon emissions.

More Info Here

4th Hellenic Biocluster Forum: Emerging Trends in Life Science Innovation
2025-03-06 08:00 - 2025-03-07 20:00
Join the 4th Hellenic Biocluster Forum for a 2-day programme discussing all the emerging trends in Life Science Innovation! Get the opportunity to meet stakeholders from the Greek and European innovation ecosystems through B2B partnering opportunities, meet exhibitors showcasing the latest technology, pitch to investors and connect to SMEs, service providers, big pharma, and academic institutions.

Keynote Speakers & RoundTables on: Scaling-up Biotechnology Innovation, Investment, Big Data & AI, Precision Medicine, Innovative Healthcare, Bio-Manufacturing, Technology Transfer into the Market

Why do you need to be at the 4th HBio Forum?

A 2-day, cutting-edge programme on the emerging trends in Life Sciences

Physical and digital B2B

Partnering Opportunities

Exhibition Booths

Opportunity to meet and present your idea to innovators, policy makers and investors

Attend site-visits to Research and Industry partners

Who should attend?

Innovators from SMEs, startups, spinoffs, big pharma, academia,

Life Sciences Clusters and Innovation Agencies

Service Providers

Policy Makers

Investors

What to expect?

Global Networking with innovators from across Greece, Europe and around the globe

Expert Insights into the latest trends, technologies and best practices in Life Sciences

Investor Connections and Pitch your idea

Opportunities Exploring Athens!

More Info Here

EFIB at BIOKET 2025
2025-03-11 08:30 - 2025-03-13 17:30
The Bioeconomy’s Key Enabling Technologies Conference & Exhibition

EuropaBio is thrilled to announce that the European Forum for Industrial Biotechnology (EFIB), and ACDV are joining forces with BIOKET 2025 in Brussels from March 11-13. This collaboration brings a significant policy-making component to our event, providing an unparalleled opportunity to shape the bioeconomy sector’s future.

Join us on March 11th for an impactful Open Plenary Session dedicated to Policy Makers:

Biotechnology & Biomanufacturing for Europe: Building a critical EU future

Biotechnology and Biomanufacturing are changing industrial ecosystems within a global race to establish resilient supply chains and competitive positions. BIOKET arrives at the heart of Europe with the technologies that drive progress and the companies that deliver outcomes. Our opening plenary will address EU ambition, industrial strategy and the framework needed for Europe to play its full role on the world stage and shape a competitive and resilient future for the European and global bioeconomy.

Register Here

CEBioForum 2025
2025-04-02 08:00 - 2025-04-03 20:00
We warmly invite you to participate in CEBioForum 2025, one of the key events for business and science in the biotechnology sector in Central Europe!

On April 2-3, 2025, at the Cambridge Innovation Center in Warsaw, biotechnology innovation leaders, scientists, companies, and investors will gather to share knowledge, experiences, and form new partnerships.

Why should you attend CEBioForum?

Business networking – Our conference brings together representatives from over 170 biotech companies, research institutes, and investors from 21 countries. It’s a perfect opportunity to expand your network, establish collaborations, and unlock new business opportunities, including through our dedicated B2B meeting application.

Expert insights – Presentations and discussion panels featuring international guests and led by top industry experts. Learn about the latest trends in biotechnology, innovation financing, commercialization of inventions, and expansion into foreign markets.

Latest innovations – Discover best practices and the newest technological advancements that can accelerate the growth of your company. Explore new funding opportunities and support for research projects.

Showcase your business – CEBioForum offers a unique chance to present your products and services to a wider audience and investors, either through presentations or an exhibition booth in our showcase area.

For over 20 years, CEBioForum has been connecting scientific and business communities, creating a space for collaboration and the development of biotechnology projects. Join us and become part of the community shaping the future of biotechnology in Central and Eastern Europe!

More Info Here

A Biotech & Life-Sciences Roadmap: how investment can reach European Start-ups and Scale-ups?
2025-04-02 12:00 - 13:00
Europe is set for a wave of long-awaited policy action in the biotech and life sciences sectors – including through a European Startup and Scaleup Strategy, a Life Sciences Strategy, and a Biotech Act.

Marking Poland’s Council Presidency of the European Union, EuropaBio National Associations Council is excited to bring you the latest edition of its usual Council Presidency Summit!

This time, in person in Warsaw, in an informal setting, we will explore the key elements of a successful national strategy for the life sciences sector and how Europe can better support its startups and scaleups to make them globally competitive. We will also explore how to bridge Eastern Europe and the Baltic nations with Western Europe, building a truly single market for biotech and life sciences products.

This discussion will be co-hosted with the Polish biotechnology association BioForum. It will be part of its upcoming CEBioForum event 2025.

If you wish for further information, and you will be attending CEBioForum, feel free to drop a message to José Peres at j.peres@europabio.org.

Location: CIC, Chmielna 73, Warsaw, Poland.

More info here

Unlocking efficiency through reliance: Navigating the EMA post-authorization framework
2025-04-03 13:30 - 15:00
This joint webinar, organised in partnership between the EMA and the industry, aims to provide a platform for discussion and awareness on current and future EMA post-authorization framework, including variations and renewals. This event builds up on last year’s session: “Regulatory Reliance Tools Unveiled – A Practical Guide by EMA.”

This year, we will further explore how EMA assessment outputs can support regulatory reliance pathways, helping to streamline the approval of variations (CMC, clinical/safety) efficiently and sustainably.

Spearheaded by EMA, with the participation of WHO and global regulators, the webinar will:

Explain EMA’s variations and renewals process.

Describe the purpose and content of assessment document outputs and their relevance for regulatory reliance.

Address participant questions to enhance understanding and application of these tools.

More Info Here

German Biotechnology Days
2025-04-09 08:00 - 2025-04-10 20:00
DBT will take place on April 9th ​​and 10th in Heidelberg. The event is considered the German forum for the biotechnology industry, where entrepreneurs exchange ideas with scientists and partners from politics, investors, funding institutions and administration. The two-day program highlights the diverse fields of application and the potential of biotechnology, from health research to the bioeconomy.

The DBT 2025 offers:

a good mix of lectures, panel discussions and breakout sessions,

more than 900 participants,

the largest and most diverse industrial exhibition to date,

a partnering platform for targeted dating and exchange,

evening networking receptions and

above all, plenty of time to get to know each other, exchange ideas and be inspired.

More Info Here

Securing Europe’s biotech future - How can biosecurity drive competitiveness?
2025-04-09 12:00 - 14:00
Biotechnology involves the use of biological systems, organisms, or their components to develop products and solutions across industries such as healthcare, agriculture, and manufacturing. In Europe, it plays an important role in advancing medicine, sustainability, and economic growth. Europe accounts for approximately 12% of the global biotech market, and discussions continue on how to maintain competitiveness in a rapidly evolving sector. Biosecurity ensures biotech technologies are used safely by managing risks and maintaining safety standards.

Often viewed in the context of risk management and regulation, it can be overlooked that biosecurity can also play an important role in innovation and market leadership. Biosecurity approaches can affect trust in biotech products, their attractiveness to investors, the scalability of new technologies, and Europe’s position in shaping global standards. As synthetic biology and advanced biomanufacturing tools develop, discussions on biosecurity frameworks and their impact on investment, trade, and competitiveness are ongoing.

Finding a balance between biosecurity measures and innovation remains a consideration for policymakers and industry stakeholders. At the same time, Europe’s role in shaping global biosecurity standards is seen as a valuable exercise in its broader economic and security strategy.

Join this Euractiv Stakeholder Workshop with our Director General Dr Claire Skentelbery to explore how biosecurity can be a strategic enabler of Europe’s biotech future. Questions to be discussed include:

How can biosecurity strengthen Europe’s competitiveness in biotech?

How can the EU develop a biosecurity approach that supports industrial growth and innovation?

What role can Europe play in shaping global biosecurity standards while maintaining its leadership in biotech?

More Info & Registration Here

Swiss Biotech Days
2025-05-05 08:00 - 2025-05-06 20:00
Since 2021, the Swiss Biotech Day has grown 40% every year and has become a premier global biotechnology conference for life sciences professionals, fostering international collaboration and impactful partnerships. In 2024 it attracted some 2,500 participants from more than 40 countries, including 17 international delegations.Join the Swiss Biotech Day to network, exchange ideas and explore advances in R&D, manufacturing, data management, AI and innovative financing. In addition, the embedded Global Village provides international delegations a platform to strengthen their ties with the Swiss biotech hub to promote cross-border investments, public-private partnerships, R&D collaborations and the exchange of best practices.

More Info Here

Knowledge for Growth 2025
2025-05-07 00:00 - 2025-05-08 23:59
Mark your calendar for Knowledge for Growth 2025, Europe’s premier life sciences conference, taking place on 8 May 2025 in the dynamic city of Antwerp, Belgium!

Connect with over 1,000 life sciences professionals from 500+ companies and organisations, including decision-makers from biotech, pharma, MedTech, AgTech, and healthtech, as well as investors, universities, research institutes, policymakers, and service providers.

Immerse yourself in an action-packed programme offering exclusive insights into the global and regional life sciences landscape, one-to-one partnering, a vibrant trade fair, and countless networking opportunities.

Don’t miss the chance to elevate your knowledge and expand your network at Knowledge for Growth 2025!

USE CODE: KFG2025CLUSTER15 FOR A 15% DISCOUNT

More Info Here

Patient BioForum 2025
2025-05-13 16:00 - 18:00
The theme of the Patient BioForum 2025 is From discovery to access: towards a patient-centric health European ecosystem.

The event is hosted by MEP András Tivadar Kulja, who will hold a keynote speech, and concluding remarks will be given by MEP Stine Bosse.

The panel discussion is moderated by Dr. Nicholas Whyte (Senior Director – APCO) and includes:

Rosa Castro (Public Affairs Director, EURORDIS),

Leire Solis, (Health Policy and Advocacy Director, IPOPI),

Solène Jouan (Policy Officer, European Patients’ Forum),

Irene de Cara Torres (Head of Policy and Government Affairs International, CSL Behring),

Dr. Claire Skentelbery (Director General, EuropaBio),

Rainer Becker (Director SANTE.D Medical Products and Innovation).

The event gathers patients organisations, industry leaders and representatives of EU institutions to discuss how the regulatory framework and future legislations (General Pharmaceutical Legislation, EU Biotech Act and Critical Medicines Act) will support innovation, availability, and access to medicines for EU patients.

EuropaBio’s Patient BioForum aims to facilitate the exchange of views and expertise on scientific, regulatory, and policy issues between patient organisations, the biopharmaceutical industry and policy makers.

For more information, please contact Beatrice Rocco: b.rocco@europabio.org

Registrations for people that do not have a badge to access the European Parliament will close at 12:00 on 6 May 2025. People that have a badge can register beyond this date.

Register Here

LifeScience4EU Conference 2025
2025-05-15 08:00 - 2025-05-16 20:00
Healthcare innovation is a complex, interconnected ecosystem that demands collaboration across research, industry, policy, and patient care. To navigate this landscape effectively, a systems-thinking approach is essential.

LifeScience4EU Conference 2025, held under the Polish Presidency of the Council of the European Union, will bring together top experts to explore how biotechnology, digital health, and next-generation medical technologies can drive meaningful change. By aligning innovation with policy and regulation, the conference aims to build a more resilient and competitive European healthcare sector.

More Info Here

EFIB Brussels Statement – a competitive future for the EU
2025-06-12 13:30 - 14:30
The EFIB Brussels statement was published following the successful workshop that EuropaBio organised together with Genopole during the Bioket conference on 11 March. It looks ahead to the decisions that the EU must now take through the policies and initiatives currently in process. A key opportunity exists for societal and industrial transformation within the sustainability and safety ambitions that make Europe a global figurehead.

The agenda of the EFIB webinar 2025 is as follows:

Presentation of the EFIB statement by our Director General, Claire Skentelbery.

Panel discussion with our wonderful participants.

Confirmed Speakers

Maarit Nyman – Senior Expert on Industrial Bioeconomy, European Commission

Ana Maria Bravo – Director of Government Affairs, IFF

Saskia Kliphuis-Schotsman – Public Affairs Manager, Corbion

Monica Christensen – Senior Public Affairs Manager, Novonesis

This will be followed by a short Q&A session.

Register Here

BIO Convention 2025 - Panel: The EU Policy Evolution and Revolution for Biotech
2025-06-18 09:00 - 10:00
Join EuropaBio in Boston for the key EU policy panel taking place at BIO 2025.

The EU is reshaping its biotechnology landscape, with the focus on competitiveness, supply and capacity resilience and societal benefit. A European Commission 5 year mandate has over 20 legislations and initiatives relevant to biotech and is an opportunity to both anchor and grow European innovation and create an attractive ecosystem for investment for global partners.

Speakers from across the European Commission will address the legislations that are the cornerstone of biotechnology performance, including the EU Biotech Act, General Pharmaceutical Legislation, Critical Medicines Act and others. These legislations aim to accelerate the growth of biotech to market and are underpinned by innovative funding models for industry from institutions such as the European Innovation Council.

Join the panel to find out how major legislative actions support innovation in the European Union and connect to the European Commission.

Moderator:

Claire Skentelbery, Director General EuropaBio

Speakers:

Carmen Laplaza Santos, Head of Unit Health Innovations and Ecosystems, DG RTD, European Commission

Giulia Del Brenna – Head of Unit – DG GROW, European Commission

Thomas Van Cangh – Deputy Head of Unit, DG Sante, European Commission

Denisa Perrin– Head of Unit, EIC Accelerator, European Innovation Council

More Info Here
